S&P 500 Futures
(0.17%) 5 336.50 points

Dow Jones Futures
(0.07%) 40 164 points

Nasdaq Futures
(0.28%) 18 687 points

Oil
(-0.46%) $79.69

Gas
(1.41%) $2.66

Gold
(0.63%) $2 432.70

Silver
(1.39%) $31.70

Platinum
(-0.84%) $1 080.80

USD/EUR
(0.09%) $0.921

USD/NOK
(0.04%) $10.68

USD/GBP
(0.07%) $0.788

USD/RUB
(-0.42%) $90.59

Realtime updates for Oxford BioMedica PLC [OXB.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences

Last Updated20 May 2024 @ 07:20

25% discount on Stockinvest.us - Use code: Podcast

0.62% £ 325.50

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 07:20):

Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally...

Stats
Today's Volume	32 728.00
Average Volume	393 490
Market Cap	325.50M
EPS	£0 ( 2024-04-29 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-2.00
ATR14	£2.12 (0.65%)

Volume Correlation

Long: -0.07 (neutral)

Short: 0.67 (moderate)

Signal:(51.246) Neutral

Oxford BioMedica PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oxford BioMedica PLC Correlation - Currency/Commodity

-0.02
( neutral )

0.01
( neutral )

-0.22
( neutral )

-0.04
( neutral )

0.08
( neutral )

-0.06
( neutral )

Oxford BioMedica PLC Financials

Annual	2023
Revenue:	£89.54M
Gross Profit:	£39.20M (43.78 %)
EPS:	£-1.630

FY	2023
Revenue:	£89.54M
Gross Profit:	£39.20M (43.78 %)
EPS:	£-1.630

FY	2022
Revenue:	£139.99M
Gross Profit:	£69.18M (49.42 %)
EPS:	£-0.480

FY	2021
Revenue:	£142.80M
Gross Profit:	£82.64M (57.87 %)
EPS:	£0.181

Financial Reports:

No articles found.

Oxford BioMedica PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Oxford BioMedica PLC

Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes. The company's products under development stage include Axo-Lenti-PD, a gene-based treatment for parkinson's disease; OXB-302, which is in pre-clinical stage for the treatment of haematological tumours; OXB-401 that is in pre-clinical stage for the treatment of liver indication; OXB-40X for liver indication; and OXB-40Y for liver indication. The company has partnerships with Novartis, Bristol Myers Squibb, Sio Gene Therapies, Orchard Therapeutics, Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Immatics, Arcellx, and Vaccines Manufacturing and Innovation Centre. The company also has a research collaboration agreement with Circularis Biotechnologies to identify novel tissue specific promoters for in vivo lentiviral gene therapy products; Virica Biotech for scaling of viral medicines; Isolere Bio provides a platform technology for tackling downstream inefficiencies in the manufacturing of biologics; and BiologIC Technologies provides novel biocomputer system for viral vector development. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.